Monthly Archives: January 2024

Lenvatinib plus pembrolizumab for advanced kidney cancer

By Sharon Deveson Kell|2024-01-18T08:54:41+00:0018 Jan 2024|Drug treatments|

The final survival information from the phase 3 CLEAR study [...]

Comments Off

Patient’s perspective on pembrolizumab/lenvatinib for kidney cancer

By Sharon Deveson Kell|2024-01-16T15:43:53+00:0016 Jan 2024|Drug treatments|

In 2009, Cesar Fuentes was first diagnosed with kidney cancer [...]

Comments Off

METEOR study: Cabozantinib compared to everolimus in advanced kidney cancer

By Sharon Deveson Kell|2024-01-09T16:10:37+00:009 Jan 2024|Drug treatments|

Cabozantinib is a tyrosine kinase inhibitor that is used [...]

Comments Off

‘No stupid questions’ for newly diagnosed kidney cancer patients

By Sharon Deveson Kell|2024-01-09T09:46:55+00:009 Jan 2024|Patient advocacy|

In this recent video interview, Dr Rachel Giles, chief executive [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Our Website Design Specialist | Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org